Theranos Whistleblower Concerns Over Billy Evans AI Startup
Left 67%
Center 33%
Right 0%
2 left · 1 center · 0 right
What happened
Billy Evans, the partner of former Theranos chief executive Elizabeth Holmes, is involved in an artificial-intelligence startup. Erika Cheung, a former Theranos employee who raised alarms about the company’s blood-testing claims, said she finds that news concerning and also said people should have opportunities to redeem themselves. Holmes was convicted in 2022 of defrauding investors over false promises about Theranos technology. Initial reports did not name the startup, describe its products, or identify its investors. Cheung’s comments were carried by The Hill and NewsNation.
Sourcing check · Fully on the record · 3 articles
2 of 2 articles cite a named source for the story. It was on the record from the first report.
What these terms mean and how they're counted
- On the record · names a source 2 of 2
- On the record means the article cites a source by name for the story's main claim: a person, or an institution speaking officially, such as a company statement or a named agency's spokesperson. The opposite is an unnamed source. The count is how many of the counted articles cite at least one such source; the names are everyone named across them, each once however the articles spell it. Here: Erika Cheung
- Primary evidence · cites a document or data 0 of 2
- Primary evidence means the article cites a record you could check yourself: a court filing or ruling, a dataset or report, a recording or transcript, an official statement or press release, market data. A quote is not a document. The count is how many articles cite one. Here: None cited.
- Credits another outlet 0 of 2
- The article says the story comes from another outlet's reporting (“first reported by Reuters”). Those articles relay the story; they are not independent confirmation. Here: Each article presents its own reporting.
- Unnamed sources 0 of 2
- The main claim is attributed to people who are not identified: “people familiar with the matter”, “officials said”. The count is how many articles do this.
- How it developed
- When the first report landed and whether it named anyone; when the first named source and the first document appeared. Here: First report Oct 26, 09:38 UTC by NewsNation, naming its source.
- Not counted 1
- Opinion, analysis and video pieces, and articles too short to assess. Every count above is out of the counted articles. An article republished under a new headline is one article.
This is about who is cited, not whether the story is true. Each source below says what it names. How we count
BLINDSPOT.
Only left-leaning outlets are covering this story
— the other side's media is silent.
Omitted — what each side leaves out
Unpacked
Right-leaning outlets had not covered this as of publication, so a reader on that side would not know a Theranos whistleblower had raised an alarm. Left-leaning coverage reports that former Theranos employee Erika Cheung finds Billy Evans's AI startup concerning, and says there should be "opportunities for people to redeem themselves." That coverage never describes the product, the company's claims, or Evans's role, so the concern cannot be judged on its merits. The silent side misses Cheung's statement altogether.
Left-leaning outlets do not treat this as the same story. Cheung's worry about the startup leads in The Hill. Slate never mentions an AI company, presenting Evans only as Holmes's partner in a film.
What does Evans's AI startup claim it can do?
Bottom line
The Hill flags Erika Cheung's concern about Billy Evans's AI startup without describing the company, and right-leaning outlets have not reported her warning.
The receipts — 4 facts one side's coverage lacks
- Former Theranos employee Erika Cheung said she finds Billy Evans's AI startup concerning
- Cheung said there should be opportunities for people to redeem themselves
- Elizabeth Holmes was convicted in 2022 of defrauding investors with false promises of blood-testing technology
- Theranos used other companies' machines to perform tests rather than delivering on its own technology
The Left View
The Hill and NewsNation both reported Cheung’s reaction in nearly identical terms: she finds Evans’s AI venture concerning but added that people should have chances at redemption. Slate, in a long essay on Nathan Fielder and Lance Oppenheim’s film You Can See Everything, does not center on the startup. It describes Fielder living with Holmes, Evans, and their children before Holmes’s prison term, argues the film’s ambiguity has led some viewers to treat Holmes’s fraud as more unknowable than the record supports, and notes Evans’s role in her life and in approaching the production. Slate also cites Theranos reporting by John Carreyrou and comments from whistleblower Tyler Shultz that the film creates ambiguity.
Our Take (balanced)
The story is thin. What is established is Cheung’s quoted reaction and that Evans is Holmes’s partner; the startup is unnamed, and the coverage cites no filings, product claims, customers, or documents. Cheung’s concern is an opinion, not a specific, checkable allegation of misconduct by the company. Nothing in these reports shows the AI venture repeating Theranos’s fraud. No right-leaning outlet has reported this. Watch for the company’s name, incorporation or funding records, public product claims, and any response from Evans or the startup.
3 sources
More stories
The week's bottom lines, in your inbox
One email a week: the five stories that mattered and what they actually mean. Free.